Structure of PDB 7lxl Chain A Binding Site BS02 |
|
|
Ligand ID | YNV |
InChI | InChI=1S/C42H60O4/c1-39-17-13-29(43)23-27(39)21-25(37-31-9-11-35(45)41(31,3)19-15-33(37)39)7-5-6-8-26-22-28-24-30(44)14-18-40(28,2)34-16-20-42(4)32(38(26)34)10-12-36(42)46/h5-6,23-26,31-38,45-46H,7-22H2,1-4H3/b6-5-/t25-,26-,31+,32+,33+,34+,35+,36+,37+,38+,39+,40+,41+,42+/m1/s1 |
InChIKey | FKJMMUCCAVJSJW-HKNCNPFKSA-N |
SMILES | Software | SMILES |
---|
ACDLabs 12.01 | O=C1CCC2(C)C3CCC4(C)C(O)CCC4C3C(CC2=C1)C\C=C/CC1CC2=CC(=O)CCC2(C)C2CCC3(C)C(CCC3O)C21 | OpenEye OEToolkits 2.0.7 | CC12CCC3C(C1CCC2O)C(CC4=CC(=O)CCC34C)CC=CCC5CC6=CC(=O)CCC6(C7C5C8CCC(C8(CC7)C)O)C | OpenEye OEToolkits 2.0.7 | C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=CC(=O)CC[C@]34C)C/C=C\C[C@@H]5CC6=CC(=O)CC[C@@]6([C@@H]7[C@@H]5[C@@H]8CC[C@@H]([C@]8(CC7)C)O)C | CACTVS 3.385 | C[C]12CC[CH]3[CH]([CH](CC=CC[CH]4CC5=CC(=O)CC[C]5(C)[CH]6CC[C]7(C)[CH](O)CC[CH]7[CH]46)CC8=CC(=O)CC[C]38C)[CH]1CC[CH]2O | CACTVS 3.385 | C[C@]12CC[C@H]3[C@@H]([C@H](C\C=C/C[C@@H]4CC5=CC(=O)CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](O)CC[C@H]7[C@H]46)CC8=CC(=O)CC[C@]38C)[C@@H]1CC[C@@H]2O |
|
Formula | C42 H60 O4 |
Name | 17alpha-hydroxy-7alpha-[(2Z)-4-(17beta-hydroxy-3-oxo-8alpha-androst-4-en-7beta-yl)but-2-en-1-yl]-8alpha,10alpha,13alpha,14beta-androst-4-en-3-one |
ChEMBL | CHEMBL4863362 |
DrugBank | |
ZINC |
|
PDB chain | 7lxl Chain A Residue 602
[Download ligand structure]
[Download structure with residue number starting from 1]
[View ligand structure]
|
|
|
|
Enzyme Commision number |
1.14.14.1: unspecific monooxygenase. 1.14.14.55: quinine 3-monooxygenase. 1.14.14.56: 1,8-cineole 2-exo-monooxygenase. 1.14.14.73: albendazole monooxygenase (sufoxide-forming). |
|
|
Molecular Function |
GO:0004497 |
monooxygenase activity |
GO:0005496 |
steroid binding |
GO:0005506 |
iron ion binding |
GO:0005515 |
protein binding |
GO:0008395 |
steroid hydroxylase activity |
GO:0008401 |
retinoic acid 4-hydroxylase activity |
GO:0016491 |
oxidoreductase activity |
GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen |
GO:0019825 |
oxygen binding |
GO:0019899 |
enzyme binding |
GO:0020037 |
heme binding |
GO:0030343 |
vitamin D3 25-hydroxylase activity |
GO:0034875 |
caffeine oxidase activity |
GO:0046872 |
metal ion binding |
GO:0050591 |
quinine 3-monooxygenase activity |
GO:0050649 |
testosterone 6-beta-hydroxylase activity |
GO:0062181 |
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity |
GO:0062187 |
anandamide 8,9 epoxidase activity |
GO:0062188 |
anandamide 11,12 epoxidase activity |
GO:0062189 |
anandamide 14,15 epoxidase activity |
GO:0070330 |
aromatase activity |
GO:0070576 |
vitamin D 24-hydroxylase activity |
GO:0101020 |
estrogen 16-alpha-hydroxylase activity |
GO:0101021 |
estrogen 2-hydroxylase activity |
GO:0102320 |
1,8-cineole 2-exo-monooxygenase activity |
|
|